Skip to main navigation Skip to search Skip to main content

SKY92 Identifies High-Risk Newly Diagnosed Multiple Myeloma With Inferior Progression-Free Survival and Implicates NUF2 as a Candidate Driver

  • Roisin M. McAvera
  • , Izabela Cymer
  • , John Quinn
  • , Phillip T. Murphy
  • , Patrick Thornton
  • , Niamh McAuley
  • , Harmony Black
  • , Omar Abdelzaher
  • , Catherine Duane
  • , Tatiana Cichocka
  • , Eva Szegezdi
  • , Meegahage Perera
  • , Gerard M. Crotty
  • , Michelle Connolly
  • , Aileen Walsh
  • , Ruth Clifford
  • , Janusz Krawczyk
  • , Teresa Meenaghan
  • , Vitaliy Mykytiv
  • , Ezzat Elhassadi
    • Mark Coyne, Robert J. Cummins, Rowan Kuiper, Michael O'Dwyer, Siobhan V. Glavey
  • Royal College of Surgeons in Ireland
  • Beaumont RCSI Cancer Centre
  • University of Galway
  • Mid-Western Regional Hospital Limerick
  • University Hospitals Limerick
  • University College Cork
  • University College Dublin
  • SkylineDx B.V.

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'SKY92 Identifies High-Risk Newly Diagnosed Multiple Myeloma With Inferior Progression-Free Survival and Implicates NUF2 as a Candidate Driver'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry